Variable Effects of Glucagon Like Peptide-1 Receptor Agonists on Body Composition in Older Women
AACE Endocrinology and Diabetes · 2026-01 · 13 (1) · 63-66
DOI: 10.1016/j.aed.2025.09.012 ↗Kurz gefasst
Fallbericht in der Zeitschrift AACE Endocrinology and Diabetes, 2026-01. Verfasst von Arshad Mohammed und 1 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic Alix School of Medicine, Mayo Clinic College of Medicine and Science, Phoenix, Arizona. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Mayo Clinic.
Abstract (Originalsprache)
Background/Objective: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improve glycemic control, promote weight loss, and enhance cardiovascular outcomes. However, their effects on lean mass in older adults are unclear. This case report describes how GLP-1 RAs influenced body composition in 2 older women. Case Report: We measured the body compositions of 2 older women with obesity, who were unable to lose weight through lifestyle changes alone, before and after taking GLP-1 RAs. The first patient (65 years old) received weekly subcutaneous injections of tirzepatide. She had a moderate reduction in body mass index over 4 months, with a modest reduction in fat mass and a substantial reduction in lean mass. The second patient (79 years old) received weekly subcutaneous injections of semaglutide and had a moderate reduction in body mass index over 6 months, with a substantial reduction in fat mass and a modest gain in lean mass. The patient with greater muscle loss was less physically active and tracked food intake less precisely than the patient with less muscle loss.
Discussion
Differences in lean mass loss between patients may be influenced by exercise and calorie counting. These findings highlight the importance of lifestyle modifications for preserving lean mass. However, because only 2 patients were studied, the results are entirely anecdotal and therefore cannot be generalized to larger populations.
Conclusion
Clinicians should consider recommending individualized exercise programs and dietary strategies for older patients taking GLP-1 RAs. Routine assessment of body composition may help guide interventions and optimize clinical outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mayo Clinic Alix School of Medicine, Mayo Clinic College of Medicine and Science, Phoenix, Arizona.
- Division of Community Internal Medicine (Mishra), Mayo Clinic, Scottsdale, Arizona.
Förderung
- Mayo Clinic
Zitieren
APA
Mohammed, A., & Mishra, S. (2026). Variable Effects of Glucagon Like Peptide-1 Receptor Agonists on Body Composition in Older Women. AACE Endocrinology and Diabetes, 13(1), 63-66. https://doi.org/10.1016/j.aed.2025.09.012
Vancouver
Mohammed A, Mishra S. Variable Effects of Glucagon Like Peptide-1 Receptor Agonists on Body Composition in Older Women. AACE Endocrinology and Diabetes. 2026;13(1):63-66. doi:10.1016/j.aed.2025.09.012
BibTeX
@article{Mohammed2026,
author = {Mohammed, Arshad and Mishra, Sneha},
title = {Variable Effects of Glucagon Like Peptide-1 Receptor Agonists on Body Composition in Older Women},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
volume = {13},
number = {1},
pages = {63--66},
doi = {10.1016/j.aed.2025.09.012}
}
EUVIMED